Gene and cell therapy is moving fast – and in a clear direction. Programs are pushing toward more complex payloads, virus-free engineering, and manufacturing models that can scale from early research ...

Moderna is scaling its mRNA production capabilities and hiring specialized engineers, as its stock surges over 75% YTD amid a shift beyond COVID-19 vaccines.

Next Conyngham used Grok to design an mRNA vaccine that boosts the production of tumor-associated antigens enabling Rosie's immune system to identify and destroy tumor cells. Once he had the vaccine ...

Existing bacteria and archaea still our universal common ancestor’s ribosomal hibernation defense mechanism when nutrients ...

Treatments that target a fragment of the mutant protein that causes Huntington's disease might be more effective than ...

The UK-Rwanda Climate Partnership Conference, convened by the Africa Centre of Excellence for Sustainable Cooling and Cold Chain (ACES), concluded on 25 March 2026 with proposed solutions to address ...

Top 10 S&P 500 large-cap winners ranked by YTD performance—see standout gainers like SNDK, VG and LITE plus quant ratings to ...

Researchers have developed a new lipid nanoparticle design that directs mRNA to the pancreas by exploiting the organ’s own ...

Vaccination policies must prioritize saving human lives over individual choice amid rising vaccine skepticism, asserts ...

UT Southwestern discovery could lead to a novel approach for treating heart disease and fatty liver disease. Two researchers ...

Why Enveda, Faeth Therapeutics, Gilgamesh Pharma, and Argo Biopharma are among the most innovative companies in biotech right ...